Fourteen of 3,304 lovastatin recipients developed melanoma during five years of follow-up, compared to 27 of 3,301 placebo patients
Discovering Last Month's Psoriasis Spotlight
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Get Ready to Test Your Atopic Dermatitis Knowledge
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
FDA Issues Complete Response Letter for Lebrikizumab
Eczema Resources for Your Patients: Week 1